Title : Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin.

Pub. Date : 2015 Mar 1

PMID : 25542900






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ritonavir and metformin effectively suppressed AKT and mTORC1 phosphorylation and prosurvival BCL-2 family member MCL-1 expression in multiple myeloma cell lines in vitro and in vivo. Metformin BCL2 apoptosis regulator Homo sapiens